I really want to thank you for going through regular order with this bill, because I think that this is one of those iss...
It has been 40 years that we have had this monograph system, but we haven't really made any updates to it.
I would like to thank you for working on this important bill with us.
What this would do is give the FDA new tools to protect consumers.
I enjoy the opportunity, always, to work with the Ranking Member, Senator Manchin, to address these key topics in Energy...
I believe our national labs are catalysts that have accelerated or made possible many innovations.
How we choose to invest in our national labs and support the scientists within them is critical going forward.
The 17 labs of the DOE are national assets that have contributed profoundly to the nation's security, scientific leaders...
I would also share the view, as a couple of you suggested that one source of great unhappiness that I hear about from pe...
Is it your understanding that the 1332 Waiver, as is it written now, would allow a State, if it wanted to, to apply to h...
If we are going to have any committee in whose hands to put our fate, we are glad it is you guys.
I really do believe you ought to make that a flexible opportunity and have States do the things that are going to work b...
There is another piece that Senator Grassley and I have been working on that I think would be wonderful to add to CHIP.....
I want to take a moment--because my questions on the cost of prescription drugs were ably asked and answered by Senator ...
We urge you in the strongest terms to renew funding for this important program through 2022 at the currently established...
And to add to that, let me say words that have not been said in the Senate before. My questions have been asked.
I would argue for transparency of prices so that consumers can have choices, and there are apps out there that could mak...
We need immediate Federal action and responsible reforms that preserve coverage gains and control costs.
